Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.
about
Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug deliveryCurrent understanding of interactions between nanoparticles and the immune systemNanocarriers Usage for Drug Delivery in Cancer TherapyTweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targetingDendrimer advances for the central nervous system delivery of therapeuticsDendrimers bind antioxidant polyphenols and cisplatin drugBiogenic and synthetic polyamines bind cationic dendrimersVirus-based nanomaterials as positron emission tomography and magnetic resonance contrast agents: from technology development to translational medicineCurrent progress in gene delivery technology based on chemical methods and nano-carriersPolymer beacons for luminescence and magnetic resonance imaging of DNA deliveryCationic PAMAM dendrimers disrupt key platelet functions.Encapsulation of acetylshikonin by polyamidoamine dendrimers for preparing prominent nanoparticles.Antibacterial activities of poly(amidoamine) dendrimers terminated with amino and poly(ethylene glycol) groupsNovel peptide-dendrimer conjugates as drug carriers for targeting nonsmall cell lung cancer.Synthesis of surface-modified TREN-cored PAMAM dendrimers and their effects on the solubility of sulfamethoxazole (SMZ) as an analog antibiotic drug.Cytotoxicity and biodistribution studies on PEGylated EDA and PEG cored PAMAM dendrimers.Collagen cross linking agents: design and development of a multifunctional cross linker.Gold nanoparticles stabilized by cationic carbosilane dendrons: synthesis and biological properties.Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: synthesis, characterization, and evaluation of cytotoxicity.Enhanced cellular uptake of a triplex-forming oligonucleotide by nanoparticle formation in the presence of polypropylenimine dendrimersPAMAM dendrimers and branched polyethyleneglycol (nanoparticles) prodrugs of (-)-beta-D-(2R, 4R)-dioxolane-thymine (DOT) and their anti-HIV activity.Antibacterial activity and cytotoxicity of PEGylated poly(amidoamine) dendrimers.Amino acid-functionalized dendrimers with heterobifunctional chemoselective peripheral groups for drug delivery applications.LARGE SCALE, GREEN SYNTHESIS OF A GENERATION-1 MELAMINE (TRIAZINE) DENDRIMER.Highly stable dendritic trityl radicals as oxygen and pH probe.Charge-reversal polyamidoamine dendrimer for cascade nuclear drug delivery.Aggregation is a critical cause of poor transfer into the brain tissue of intravenously administered cationic PAMAM dendrimer nanoparticles.On the Possibility of Facilitated Diffusion of Dendrimers Along DNA.Liquid crystalline phases of dendritic lipid-DNA self-assemblies: lamellar, hexagonal, and DNA bundlesPhysicochemical and biological properties of self-assembled antisense/poly(amidoamine) dendrimer nanoparticles: the effect of dendrimer generation and charge ratioFabrication, characterization and in vitro evaluation of poly(D,L-lactide-co-glycolide) microparticles loaded with polyamidoamine-plasmid DNA dendriplexes for applications in nonviral gene delivery.Design, synthesis, and biological evaluation of a robust, biodegradable dendrimer.Structure-skin permeability relationship of dendrimers.Enhanced gene and siRNA delivery by polycation-modified mesoporous silica nanoparticles loaded with chloroquine.Partially glycosylated dendrimers block MD-2 and prevent TLR4-MD-2-LPS complex mediated cytokine responses.Labile catalytic packaging of DNA/siRNA: control of gold nanoparticles "out" of DNA/siRNA complexesRGD dendron bodies; synthetic avidity agents with defined and potentially interchangeable effector sites that can substitute for antibodies.Controlled drug delivery systems: past forward and future back.Lipid and polymeric carrier-mediated nucleic acid delivery.Bioengineering strategies for designing targeted cancer therapies
P2860
Q24616011-2814011A-3CD2-4DE5-B500-D95114BD7FD5Q26345204-C7A300DA-F6FE-4421-8ED5-8B3875AD5E6AQ26740048-1F479C64-32D9-4C47-A77F-D6EBB5F6F7F7Q26785347-E61F946C-5F88-441A-BE11-B997F070289DQ26828423-4847466A-EEA1-41A2-86FD-6BC779D9C692Q27307187-3A87A516-4A3B-4F81-8F33-076A901DA82AQ28482718-5D8E7EC6-8BC6-45CF-8A61-570D09BEC26BQ28550482-A5C4056E-20F3-4970-BA1D-6C879AE98A41Q28659480-D2DDA788-0F5B-4AAF-B982-1A4F78EC9C30Q30490915-03E61D4B-C2B2-4FBA-A149-4E7E9717EC9EQ30514562-1B6B656F-D72F-43C2-9261-88282E003B71Q30739130-690B80EB-3BD0-4455-9F93-CDA0451E1787Q30831776-7F89A7B9-79C0-472E-91EF-2FD99944AF07Q30997567-50B593F7-4DCB-4640-8E92-1484068B2C82Q31119728-5EA12CBD-2987-4AA1-A2E3-D1EF0F440269Q31122095-5864D386-D7D9-41E4-A736-1DA9C2D68BB0Q31141823-91FC2B10-5810-49B6-A3BC-D10F3BE81BF6Q31154862-F339312F-A399-4A4A-B883-2B3BD97FCFA4Q31161948-4745D76E-AE3D-4356-A584-94CDD869EF09Q33201676-9998CA53-4563-4254-BD1F-B7EF981A60EAQ33270151-DA21E5A0-2C8B-4F12-B2A3-9A0D630968BFQ33503674-97BD7947-29B9-4264-9325-07592C314F39Q33563098-1C1AE153-8B2C-4191-B880-F70A0E063D31Q33585046-84D5486B-BC53-433D-A6C7-4C33F77627F6Q33694227-7AC3F8B2-68E6-4826-9F7A-2E6C88505AC9Q33734954-EF73590D-88B4-4A71-B120-F40ED6B1CF04Q33739963-A03175F4-027A-432F-823E-B3B7AC974546Q33789970-8A43D7E6-2B4A-437F-99C9-72E3B64EA3ECQ33806674-5EC2DF2E-446A-4994-A529-963FB0BE0193Q33874029-07E21ACC-4BAC-49D7-B4AF-7EBE6EC85F12Q33899121-0957E38B-369D-4926-A19F-007356B78F70Q33910306-52157623-A97A-4B0B-83D3-359C53DEAA1AQ33919858-748FA370-BB05-4E3E-9407-6774FB7321BCQ33940884-B7722D42-3853-49D3-AB7C-7F5456B1BF54Q33954358-71F4065F-91AD-45B1-9F71-82E0FDF407ADQ34058107-EBFC8FC3-8BBD-4D74-82B4-E3DC07C3A067Q34062177-DBBFC702-1AC1-46DD-92B7-D2D4FC977C9BQ34079613-818C7FCB-899B-4E90-A1D9-C3B5B0DF0C78Q34155795-B6DD4752-7CB1-4A19-99D4-910111EBC26AQ34194191-4B81C990-EBA0-446A-BDE1-BA947E62FC13
P2860
Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Dendrimers: relationship betwe ...... amidoamine dendrimers in vivo.
@ast
Dendrimers: relationship betwe ...... amidoamine dendrimers in vivo.
@en
type
label
Dendrimers: relationship betwe ...... amidoamine dendrimers in vivo.
@ast
Dendrimers: relationship betwe ...... amidoamine dendrimers in vivo.
@en
prefLabel
Dendrimers: relationship betwe ...... amidoamine dendrimers in vivo.
@ast
Dendrimers: relationship betwe ...... amidoamine dendrimers in vivo.
@en
P2093
P1476
Dendrimers: relationship betwe ...... amidoamine dendrimers in vivo.
@en
P2093
Wiwattanapatapee R
P304
P356
10.1016/S0168-3659(99)00246-1
P407
P50
P577
2000-03-01T00:00:00Z